Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Quest Diagnostics Inc (DGX)

Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Do Wall Street Analysts Like Quest Diagnostics Stock?

Secaucus, New Jersey-based Quest Diagnostics Incorporated (DGX) provides diagnostic testing and services in the United States and internationally. Valued at a market capitalization of $23 billion, the company develops and delivers diagnostic information services, including routine, non-routine, and advanced clinical testing, anatomic pathology testing, and other diagnostic services.

The company's shares have outperformed the broader market over the past year and in 2026. DGX stock has surged 21.8% over the past 52 weeks and 18.4% on a YTD basis. In comparison, the S&P 500 Index ($SPX) has returned 11.9% over the past year and declined marginally in 2026.

Fundamentals

See More
  • Market Capitalization, $K 22,859,118
  • Shares Outstanding, K 111,242
  • Annual Sales, $ 11,035 M
  • Annual Income, $ 992,000 K
  • EBIT $ 1,710 M
  • EBITDA $ 2,280 M
  • 60-Month Beta 0.66
  • Price/Sales 2.09
  • Price/Cash Flow 13.63
  • Price/Book 3.19

Options Overview Details

View History
  • Implied Volatility 22.28% (-0.66%)
  • Historical Volatility 31.19%
  • IV Percentile 57%
  • IV Rank 23.19%
  • IV High 39.40% on 04/11/25
  • IV Low 17.11% on 08/15/25
  • Expected Move (DTE 2) 4.58 (2.23%)
  • Put/Call Vol Ratio 27.27
  • Today's Volume 735
  • Volume Avg (30-Day) 860
  • Put/Call OI Ratio 1.20
  • Today's Open Interest 18,445
  • Open Int (30-Day) 12,020
  • Expected Range 200.80 to 209.96

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 2.38
  • Number of Estimates 9
  • High Estimate 2.51
  • Low Estimate 2.21
  • Prior Year 2.21
  • Growth Rate Est. (year over year) +7.69%

Price Performance

See More
Period Period Low Period High Performance
1-Month
179.73 +14.06%
on 01/23/26
213.20 -3.85%
on 02/12/26
+15.51 (+8.19%)
since 01/16/26
3-Month
171.18 +19.76%
on 01/05/26
213.20 -3.85%
on 02/12/26
+19.68 (+10.62%)
since 11/18/25
52-Week
157.20 +30.41%
on 04/09/25
213.20 -3.85%
on 02/12/26
+35.35 (+20.84%)
since 02/18/25

Most Recent Stories

More News
Do Wall Street Analysts Like Quest Diagnostics Stock?

Quest Diagnostics has outperformed the broader market over the past year, and analysts remain somewhat bullish about the stock’s prospects.

XLV : 157.04 (-0.21%)
DGX : 204.78 (-0.35%)
$SPX : 6,900.50 (+0.84%)
5 Insightful Analyst Questions From Quest’s Q4 Earnings Call

5 Insightful Analyst Questions From Quest’s Q4 Earnings Call

DGX : 204.78 (-0.35%)
DGX Q4 Deep Dive: Consumer Testing and Advanced Diagnostics Fuel Growth Amid Margin Headwinds

DGX Q4 Deep Dive: Consumer Testing and Advanced Diagnostics Fuel Growth Amid Margin Headwinds

DGX : 204.78 (-0.35%)
Why Is Quest (DGX) Stock Soaring Today

Why Is Quest (DGX) Stock Soaring Today

DGX : 204.78 (-0.35%)
Quest Diagnostics: Q4 Earnings Snapshot

Quest Diagnostics: Q4 Earnings Snapshot

DGX : 204.78 (-0.35%)
Quest’s (NYSE:DGX) Q4 CY2025: Beats On Revenue

Quest’s (NYSE:DGX) Q4 CY2025: Beats On Revenue

DGX : 204.78 (-0.35%)
Quest Diagnostics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Guidance for Full Year 2026; Increases Quarterly Dividend 7.5% to $0.86 Per Share

SECAUCUS, N.J. , Feb. 10, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, announced today financial results for the fourth...

DGX : 204.78 (-0.35%)
Quest Diagnostics Increases Dividend 7.5% To $0.86 Per Quarter, Marking 15 Consecutive Years of Dividend Increases; Announces $1 Billion Increase in Share Repurchase Authorization

SECAUCUS, N.J. , Feb. 10, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced that the Company's Board of Directors...

DGX : 204.78 (-0.35%)
Quest (DGX) Q4 Earnings: What To Expect

Quest (DGX) Q4 Earnings: What To Expect

DGX : 204.78 (-0.35%)
Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease

New test as sensitive as next-generation sequencing, and provides five-day specimen stability to support nationwide testing

DGX : 204.78 (-0.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 70%. The market has dropped from overbought territory. Beware of a potential mean reversion.

See More Share

Business Summary

Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services...

See More

Key Turning Points

3rd Resistance Point 214.78
2nd Resistance Point 211.85
1st Resistance Point 208.67
Last Price 204.78
1st Support Level 202.57
2nd Support Level 199.64
3rd Support Level 196.46

See More

52-Week High 213.20
Last Price 204.78
Fibonacci 61.8% 191.81
Fibonacci 50% 185.20
Fibonacci 38.2% 178.59
52-Week Low 157.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar